BSE filing, BSE: 544353. Summary written from the filing by ALFA Finder's alert engine.
Amwill Health Care Ltd: key numbers
- Share price
- ₹42.10
- Market cap
- ₹84.22 Cr
- Revenue (annual)
- ₹45.49 Cr
- Net profit (annual)
- ₹11.42 Cr
- P/E (TTM)
- 7.4×Sector 47.2×
- Promoter holding
- 70.65%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amwill Health Care Ltd
All →Amwill Health Care Dividend
Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.
Amwill Health Care H1 FY27 Results: Net Profit ₹3.7 Cr, Down 50.7% YoY
Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.7 Cr · -50.7% YoY
Amwill Health Care Other Announcement
This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.
Amwill Health Care Regulatory Approval
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.
Amwill Health Care Acquisition Worth ₹3 Cr
Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.
- Value
- ₹3.00 Cr
- Execution
- Ensuing month(s)
Amwill Health Care Management Change
Amwill Health Care Ltd re-appointed Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for a five-year term, effective January 27, 2027.
- Execution
- 5 years
Other board meeting date announcements
All →Choksi Asia Board Meeting Date
Choksi Asia Ltd intimated that its Board meeting is scheduled for 12 Nov 2026 to consider unaudited Q1 and H1 FY27 results. No financial figures or decisions are reported in this advance notice.
Precision Camshafts Board Meeting Date
Precision Camshafts Limited has scheduled a board and audit committee meeting on 6 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from 1 October to 8 November 2026.
NAVA Board Meeting Date
Nava Ltd intimated that its Board meeting is scheduled for 12 Nov 2026 to consider unaudited Q2 FY27 results. No financial figures or decisions are reported yet as the meeting has not been held.
B L Kashyap & Sons Board Meeting Date
BL Kashyap and Sons scheduled a Board Meeting for 12 Nov 2026 to approve Q2 FY27 unaudited results. No financial figures are disclosed in this advance intimation.
Northern Spirits Board Meeting Date
Northern Spirits Limited issued a prior intimation that its Board meeting is scheduled for 12 Nov 2026 to consider unaudited Q2/H1 FY27 results. Trading window remains closed till 14 Nov 2026.
Pan Electronics India Board Meeting Date
PAN Electronics (India) intimated a board meeting on 13 November 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from 1 October to 18 November 2026.